-+ 0.00%
-+ 0.00%
-+ 0.00%

Cocrystal Pharma Q3 2024 GAAP EPS $(0.49) Beats $(0.52) Estimate

Benzinga·11/13/2024 13:07:50
Listen to the news
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.52) by 5.77 percent.